Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Screening for factor V Leiden mutation in women using combined hormonal contraceptives or hormone replacement therapy].

Ceska gynekologie - 1 May 2003

Cibula D, Unzeitig V, Zivný J

Abstract excerpt

OBJECTIVE: Analysis of the issue of screening for Factor V Leiden mutation (FVL) in users of combined oral contraceptives (COC) or hormone replacement therapy (HRT). DESIGN: Review article. SETTING: Department of Obstetrics and Gynecology, Charles University and General Faculty Hospital, Prague. METHODS: Review of published facts, analysis of possibilities to screen all users or to test risk groups in the current...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contraceptives, Oral, Hormonal
Share to Estrogen Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Genetic Markers

Share to Genetic Predisposition to Disease

Share to Point Mutation

Share to Risk Factors

Share to Thrombophilia

Source

Identifiers

PMID: 12879655

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Screening for factor V Leiden mutation in women using combined hormonal contraceptives or hormone replacement therapy].PMID 12879655Read ↗

Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?Semantic proximity Read ↗

Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read ↗

[Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].Semantic proximity Read ↗

[Deep venous thrombosis associated with the taking of oral contraceptives: the existence of Leiden factor V?].Semantic proximity Read ↗

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.Semantic proximity Read ↗

[From pill to pill: oral contraception, venous thrombosis and coagulation disorders].Semantic proximity Read ↗

Oral contraceptives and screening for factor V Leiden.Semantic proximity Read ↗

[Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation].Semantic proximity Read ↗

Screening for factor V Leiden mutation before prescribing combination oral contraceptives.Semantic proximity Read ↗

Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.Semantic proximity Read ↗

[Combined hemostatic defects in family members of symptomatic carriers of Leiden mutations of factor V].Semantic proximity Read ↗

Thrombosis risk with the use of hormonal contraception among women with thrombophilia: An updated systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.